Two weeks ago GILD added Arm-17, and Arm-18 to this ongoing study. So testing of Sofosbuvir/GS-5885 and Sofosbuvir/5885/riba in GT2/GT3 has begun. Edit: Arm-18 and Arm-19 are GT2/GT3 without riba.